DISCOUNT ZERTIFIKAT - BIOGEN IDEC | Delayed Deutsche Boerse AG 08:33:36 07/06/2024 pm IST | ||
| 179.4 EUR | +0.35% |
|
| Current month | +0.57% | ||
| 1 month | +0.87% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 07/24/07 | 179.4 | +0.35% |
| 06/24/06 | 178.8 | -0.10% |
| 05/24/05 | 179 | +0.44% |
| 04/24/04 | 178.2 | +0.23% |
| 03/24/03 | 177.8 | 0.00% |
Delayed Quote Deutsche Boerse AG
Last update June 07, 2024 at 08:33 pm IST
More quotesStatic data
| Product type | Discount Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VM5USE |
| ISIN | DE000VM5USE9 |
| Date issued | 22/11/2023 |
| Maturity | 20/09/2024 (105 Days) |
| Parity | 1 : 1 |
| Emission price | 170.2 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 179.4 € |
|---|---|
| Lowest since issue | 165.9 € |
| Spread | 0.22 € |
| Spread % | 0.12% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
232
USD
Average target price
284.6
USD
Spread / Average Target
+22.70%
- Stock Market
- Certificates
- Certificat
